BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 101125)

  • 21. Free light chain synthesis by neoplastic cells in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.
    Gordon J; Howlett AR; Smith JL
    Immunology; 1978 Mar; 34(3):397-404. PubMed ID: 417018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of cell-surface markers in chronic lymphocytic leukaemia (CLL).
    Rak K; Pecze K; Kiss A; Telek B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(3):294-300. PubMed ID: 6205953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B-1a cell origin of the murine B lymphoma line BCL1 characterized by surface markers and bacterial reactivity of its surface IgM.
    Koganei S; Ito M; Yamamoto K; Matsumoto N
    Immunol Lett; 2005 May; 98(2):232-44. PubMed ID: 15860223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic value of immunological lymphocyte differentiation].
    Zortea-Caflisch C; Odermatt B; Rüttner JR; Grob PJ
    Schweiz Med Wochenschr; 1975 Dec; 105(52):1805-14. PubMed ID: 814618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
    Solomon A; Weiss DT; Macy SD; Antonucci RA
    Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis and detection of B cell neoplasms.
    Frenkel EP; Smith RG; Ligler FS; Hernandez J; Himes JB; Sheehan RG; Vitetta ES; Kettman JR; Uhr JW
    Blood Cells; 1980; 6(4):783-98. PubMed ID: 6781556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
    Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
    Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two maturation-associated mouse erythrocyte receptors of human B cells. I. Identification of four human B-cell subsets.
    Forbes IJ; Zalewski PD; Valente L; Gee D
    Clin Exp Immunol; 1982 Feb; 47(2):396-404. PubMed ID: 6978783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte responsiveness to mitogens and quantitation of T and B lymphocytes in canine malignant lymphoma.
    Dutta SK; Novilla MN; Bumgardner MK; Ingling A
    Am J Vet Res; 1978 Mar; 39(3):455-8. PubMed ID: 305738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of T and B cell populations in some lymphoproliferative disorders.
    Herzog P; Stöckbauer P
    Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human B-cell antigens in acute lymphocytic leukemia. Lack of correlation with other lymphocyte surface markers.
    Mann DL; Kundsen BB; Yarbro GC; Leventhal BG
    J Natl Cancer Inst; 1979 Jul; 63(1):49-53. PubMed ID: 156279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood.
    Braylan RC; Jaffe ES; Burbach JW; Frank MM; Johnson RE; Berard CW
    Cancer Res; 1976 May; 36(5):1619-25. PubMed ID: 773529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A rapid, single step technique for determination of B and T cell surface markers in malignant lymphoid cells.
    Trigg ME; Wesley RA; Holiman BJ; Cole DE; Poplack DG
    Exp Hematol; 1982 Sep; 10(8):668-74. PubMed ID: 6982827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of immunoglobin G on blood lymphocytes in chronic lymphocytic leukaemia.
    Dhaliwal HS; Ling NR; Bishop S; Chapel H
    Clin Exp Immunol; 1978 Feb; 31(2):226-36. PubMed ID: 417884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies of cell content and surface and secretory immunoglobulins in myeloma, macroglobulinemia, malignant lymphoma and related leukemic diseases].
    Miyoshi K; Kosaka M; Tamora R; Numata Y; Takamato M
    Nihon Rinsho; 1976 May; 34(5):945-53. PubMed ID: 824476
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitogen activation of human chronic lymphatic leukemia cells. I. Synthesis and secretion of immunoglobulin.
    Maino VC; Kurnick JT; Kubo RT; Grey HM
    J Immunol; 1977 Mar; 118(3):742-8. PubMed ID: 403235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogenic stimulation of malignant B cells. Chronic lymphocytic leukaemia: relationship between stimulation and surface phenotype.
    Bloem AC; Bast EJ; Gmelig Meyling FH; DeGast GC; Ballieux RE
    Clin Exp Immunol; 1982 Nov; 50(2):355-9. PubMed ID: 6983937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
    Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
    Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.